💨 Abstract

MiMedx Group Inc. reported a first-quarter profit of $7 million, amounting to 5 cents per share on an unadjusted basis and 6 cents per share when adjusting for one-time gains and costs. The revenue for the period was $88.2 million. The company, based in Marietta, Georgia, specializes in developing biomaterials derived from sterilized human amniotic membrane.

Courtesy: wtop.com

Summarized by Einstein Beta 🤖